The mechanism of low-affinity NGF receptor (LNGFR) truncation was investigated in cultured Schwann cells. Affinity labeling of Schwann cells with Y-NGF or metabolic labeling with %-cysteine showed that truncated NGF receptor (NGFRf) was derived from the cell surface form of the receptor. Addition of full-length, exogenous NGF receptor (M, = 80 kDa) to Schwann cell membranes resulted in cleavage of the exogenous substrate to NGF-Rt. Investigations into the mechanism of truncation revealed that metalloprotease inhibitors such as phenanthroline, bathophenanthroline, and 8-hydroxyquinoline (8-OHQ) blocked LNGFR truncation in a concentration-dependent fashion. Inhibitors of other protease classes had no effect on truncation.
In addition, truncation did not occur at 4°C. It was found that truncation could also occur in Schwann cell membrane preparations, indicating that the putative protease was membrane bound and closely associated with the LNGFR. Metal reconstitution experiments revealed a strong preference toward zinc for the truncating activity, with iron and manganese having slight reconstitution activity in phenanthroline-quenched membranes. To determine if apparent truncation could be inhibited in vivo, the metalloprotease inhibitor 8-OHQ was administered to neonatal rats. 8-OHQ resulted in decreased urine and blood NGF-Rt levels and increased the sciatic nerve LNGFR content; this effect was dose dependent.
In adult rats with sciatic nerve crush lesions, t.i.d.) significantly enhanced the rate of sensory neuron regeneration as assessed by the nerve pinch assay. This was accompanied by increased levels of LNGFR in distal nerve segments.
These results suggest that Schwann cells possess a metalloprotease-like activity that serves to cleave LNGFR from the surface of these cells. We propose that the putative metalloprotease represents a novel mechanism by which the Schwann cell regulates this particular cell surface protein. Furthermore, increasing the amount of Schwann cell surface LNGFR appears to be of functional significance in that sensory nerve regeneration can be enhanced by inhibition of truncation.
[Key words: low-affinity NGF receptor, truncation, metalloprotease, enzyme inhibition, development, regeneration]
The developmental regulation of low-affinity NGF receptors (LNGFRs) on Schwann cells raises questions as to the physiological role of these binding sites on peripheral glia. Studies have shown that LNGFRs are present in high concentrations in prenatal and neonatal peripheral nerve and that levels of receptor decline with development, such that adult nerve maintains very low levels of the receptor (Yan and Johnson, 1987) . Similarly, Schwann cells isolated from embryonic day 18 (E 18) sciatic nerve contain severalfold more NGF binding sites than their postnatal day 3 (P3) counterparts (DiStefano and Johnson, 1988a) . Following lesion of adult peripheral nerve, LNGFR is reexpressed on all Schwann cells distal to the site of lesion (Taniuchi et al., 1986; Heumann et al., 1987b) . It has been proposed ) that loss of axonal contact signals the Schwann cell to synthesize LNGFR for the purpose of binding, and thus sequestering NGF (produced in part by Schwann cells) on the Schwann cell surface, forming a permissive environment for NGF-dependent axons to grow through. This model may be tenable for both developing and regenerating axons. The fact that NGF binding sites on Schwann cells are of the low-affinity form, and do not internalize bound NGF (DiStefano and Johnson, 1988a) , strongly suggests that NGF receptors are present on Schwann cells for the benefit of developing or regenerating axons. However, Schwann cell LNGFR may play a role in cell adhesion, Schwann cell migration (Anton and Matthew, 1992) , or modulation of signal transduction. In addition to this unique expression and regulation of LNGFR on the Schwann cell surface, it has recently been shown that Schwann cells shed a truncated form of the NGF receptor (NGFRt) into their extracellular space (DiStefano and Johnson, 1988b) . NGF-Rt has a net molecular weight of -50 kDa compared to 75-80 kDa for the cell surface receptor. It is LNGFR-like by virtue of the fact that it specifically binds NGF and is recognized by the anti-rat LNGFR monoclonal antibody 192-IgG (DiStefano and Johnson, 1988b) . In addition, the amino terminus of NGF-Rt purified from human amniotic fluid is identical to that deduced from the cDNA for human LNGFR and suggests a truncation site at or near the transmembrane region of the molecule (Zupan et al., 1989) . In vitro, pure Schwann cell cultures shed increasing amounts of NGF-Rt into their medium with time. Several other LNGFR-bearing cells also shed NGFRt in culture, but not to the extent of Schwann cells. In vivo, NGF-Rt is found in the plasma and the urine of neonatal rats in extremely high levels. NGF-Rt is developmentally regulated in that urine and plasma levels of the shed receptor decline very rapidly after birth (t,,, = 4-7 d), reaching 5% of Pl levels at 4 et al. l Mechanism of Low-Affinity NGF Receptor Truncation weeks of age. A similar developmental regulation has been demonstrated for human 199 1) . Following adult rat sciatic nerve transection, NGF-Rt is increased threeto fourfold 1 d after lesion and remains elevated for 2 weeks postaxotomy. We postulate that NGF-Rt regulation follows that of LNGFR on the Schwann cell surface during the course of development and during regeneration (DiStefano and Chelsea, 1990) .
were placed on ice and media were removed. Media were centrifuged 15,000 x g for 10 min, and the supernatant was removed and stored at -80°C. The cells were washed, manually scraped from the dishes in 0.5 ml of PBS/BSA on ice, and pelleted by centrifugation at 12,000 x g for 1 min. Cells were stored at -80°C until immunoprecipitation of LNGFR and NGF-Rt species (see below).
Metabolic labeling of Schwann cells. Schwann cells were plated (5 x lo5 cells) in 35 mm culture dishes and washed 1 hr in cysteine-free medium. Cells were pulsed for 4 hr with 0.5 mCi of 'S-cysteine (Amersham, Arlington Heights, IL) in normal medium containing one-third the normal cysteine content. Cells were chased with 2 x cysteine medium for O-24 hr. In other experiments cells were chased for 4 hr in the presence or absence of various protease inhibitors. Following the chase periods, cells and media were collected and stored as described above.
The physiological significance of LNGFR truncation remains unclear. Perhaps one way to understand how this protein functions is to inhibit the truncation process and observe the cellular and functional consequences of inhibiting NGF-Rt production. In the present study we have examined the effects of various protease inhibitors on LNGFR truncation in Schwann cells in an attempt to identify the class of protease involved in truncation of the LNGFR to NGF-Rt. Our results provide evidence that a metalloprotease is involved in the truncation of LNGFR. Furthermore, inhibition of the putative metalloprotease activity in vivo enhances the regeneration rate of peripheral sensory neurons. We propose that LNGFR truncation represents a novel means of regulating the Schwann cell surface content of LNGFR during development and regeneration.
Materials and Methods
Materials Carrier-free Na1251 (100 mCi/ml) was purchased from Amersham (Arlington Heights, IL). The following compounds were purchased from Sigma (St. Louis, MO): Ala-Ala-Phe-chloromethylketone (Ala-Ala-Phe-CMK), bathophenanthroline, bestatin, bovine serum albumin (BSA), carbobenzoxy (Cbz)-Gly-Phe, diisopropylfluorophosphate (DFP), dithiothreitol, ethylenediamine tetra-acetate (EDTA), 8hydroxyquinoline hemisulfate (8OHQ), iodoacetamide, leupeptin, phenylmethylsulfonyl fluoride (PMSF), 1 , 1 0-phenanthroline, phosphoramidon. Thiorphan was purchased from Bachem Bioscience (Philadelphia, PA). Ethyldimethylamino carbodiimide (EDAC) was from Pierce (Rockford, IL). Collagenase was purchased from Worthington (Freehold, NJ). Sodium pentobarbital was obtained from Abbott Laboratories (Abbott Park, IL). All other reagents were of analytical grade and purchased from standard chemical sources.
Preparation of afinity-labeled Schwann cell membranes. Schwann cells were affinity labeled as described above and osmotically shocked in 400 ~1 of ice-cold 20 mM phosphate buffer, pH 7.4. Cells were further disrupted by 3 x 2 set blasts with a cell sonicator. The resulting membranes were centrifuged 700 x g for 10 min to pellet nuclei, large debris, and unlysed cells. The resulting supematant was centrifuged 50,000 x g for 20 min in a Beckman TL-100 rotor. The pelleted membranes were resuspended in PBS/BSA on ice; 200 ~1 aliquots were incubated with or without inhibitors for 4 hr at 37°C. Following this incubation membranes were centrifuged at 106,000 x g for 20 min. Membranes and supematants were stored at -80°C until immunoprecipitation of LNGFR and NGF-Rt, respectively.
Immunoprecipitation of NGF receptor species. Cells and membranes ContainingLNGFR were solubilizedin 2% octylglucoside in 0.5 M NaCl and 0.5% sucrose. DH 7.4. for 1 hr at 4°C. Samoles were clarified bv centrifugation at 15,000 x' g for 10 min. Samples containing LNGFR and NGF-Rt were incubated with 192-IgG (Chandler et al., 1984) and the 192-IgG-receptor complexes precipitated with rabbit anti-mouse IgG adsorbed to Staphylococcus aureus cells (Pansorbin, BoehringerMannheim). Precipitates were boiled in SDS containing 2% mercaptoethanol, and 1251-NGF receptor species were visualized by SDS-acrylamide gel electrophoresis (SDS-PAGE) as described (DiStefano and Johnson, 1988a,b) . For metabolic labeling studies, immunoprecipitates were washed twice in standard RIPA buffer, and visualized by fluorography. The intensities of gel bands associated with LNGFR or NGFRt were quantified using an LKB Ultroscan XL laser densitometer. Arbitrary densitometric units are expressed as percentage of control (PBS) treated samples.
whichZcontains a whole-(-Sb kDa), soluble form of the LNGFR (DiStefano and Johnson, 1988b) was incubated with mouse Schwann SCG-conditioned medium experiments. Schwann cells and Schwann cell membranes were prepared from Pl mice as described for the rat. Rat sunerior cervical aanalion (SCG)-conditioned medium (SCG-CM).
Methods Schwann cell cultures. Schwann cells were isolated from the sciatic cells or mouse Schwann cell membranes for O-24 hr at 37°C. Media nerves of E21 rats as described (DiStefano and Chelsea, 1990) . Cells from membrane and whole-cell experiments were prepared as described were plated in 25 cm2 flasks for 3-5 d before use in experiments. It has above and stored at -80°C. Affinity labeling of soluble receptor species been determined that after this time in culture LNGFRs are highly with lz51-NGF followed by EDAC cross-linking, 192-IgG immunopreexpressed on the Schwann cell surface and that truncation is fully evident cipitation, and SDS-PAGE was carried out (DiStefano and Johnson. (DiStefano and Johnson, 1988a,b) .
Afinity labeling of Schwann cells with lz51-NGF. NGF was radioiodinated to specific activities of 1500-2900 cpm/fmol by the lactoperoxidase method as described (Marchalonis, 1969; Yip and Johnson, 1983) . Schwann cells were harvested and washed in phosphate-buffered saline containing 0.1% BSA (PBSBSA). Normally, 6-8 x lo6 cells were resuspended in 1 ml of PBS/BSA to which was added 1 ml of lZ51-NGF to a final concentration of 4-8 nM. After binding for 20 min at 23°C 1 mM EDAC (final concentration) was added and the NGF was crosslinked to Schwann cell LNGFR on ice for 20 min. The cross-linking reaction was quenched by the addition of 12 ml of PBS/BSA containing 20 mM glycine for 10 min on ice. Cells were centrifuged and resuspended in normal Schwann cell medium (Dulbecco's Modified Eagle Medium, 10% fetal calf serum). Five hundred microliter aliquots of cells containing 5 x lo5 cells were added to 24 well culture dishes (Falcon), and incubated for O-24 hr at 37°C in a humidified atmosphere containing 5% CO,. Various protease inhibitors were added as 100 x stock solutions immediately after cell plating. In some experiments, cells were placed at 4°C to assess the effects of temperature on NGF-Rt formation. Initial studies showed that, following this labeling procedure, Schwann cells attached to the dish 1 hr after replating. At 24 hr cells were morphologically and metabolically intact as assessed by phase-contrast microscopy and 3SS-methionine incorporation in cells cross-linked to unlabeled NGF (data not shown). After the various incubation times cells 1988b) to identify whole and truncated NGF receptor species in the conditioned media following incubations with whole Schwann cells or membranes.
Zon reconstitution experiments. Schwann cell membranes were affinity labeled as described above and incubated with 1 mM phenanthroline for 1 hr at 4°C to quench metalloprotease activity. The membranes were washed and resuspended in PBS/BSA containing 3 x lo-' M concentrations of zinc, iron, calcium, magnesium, manganese, or copper as the chloride or sulfate salts. Truncation was allowed to occur at 37°C for 4 hr, at which time the samples were chilled to 4°C and centrifuged 106,000 x g for 20 min. NGF receptor species were immunoprecipitated with 192-IaG and visualized on 10% acrvlamide aels as described above. Rest&s were quantified densitometrically and-kxpressed as the ratio of NGF-Rt:LNGFR (medium:membrane-associated receptor). In vivo studies: neonates. 8-Hydroxyquinoline hemisulfate (8-OHQ) was dissolved in distilled water, filtered through a 0.2 p filter, and injected subcutaneously into Pl rats (Sasco, Madison, WI) at doses of 25, 50, 75, and 100 mg/kg three times daily for 3 d. At this time rats were decapitated and trunk blood was collected in heparinized tubes; urine was also collected and pooled within the various treatment groups. A 1.0 cm section of sciatic nerve from each side was also harvested. NGF-Rt in blood and urine was estimated and quantified as described (DiStefano and Johnson, 1988b) . Sciatic nerve NGF receptor was assayed by the method of Yan and Johnson (1987) and expressed as In vivo studies: adults. Male Svraaue-Dawlev rats weiahina 225-250 gm were purchased from Sasco, housed individually for 17 d prior to an experiment, and given food and water ad libitum. Rats were anesthetized with 50 mg/kg sodium pentobarbital, and a crush lesion was performed on the right sciatic nerve at the level of the tendon of the obturator intemus muscle. The crush was made uniformly by compressing the nerve for 10 set with a #5 jeweler's forceps using a hemostat compressed to the first notch. Overlying muscle and dermis were sutured and the animals allowed to recover 2-l 1 d in initial experiments. At various times, nerves were exposed, the crush site identified, and the distance of sensory regeneration determined using the nerve pinch test as described (Young and Medawar, 1940; McQuarrie et al., 1977) . Persons performing the pinch tests were blinded to the treatment of the animals. A second, blinded observer verified the scoring of the pinch test. Distances of sensory nerve regeneration with time (rate) were compared in rats receiving 50-300 mg/kg of 8-OHQ three times daily (s.c.) versus vehicle (sterile, distilled water). Initially, regeneration distances were monitored over 2-8 d following crush. For dose-response studies regeneration rates were monitored at 3 d postcrush, as both LNGFR mRNA (Heumann et al., 1987a) and LNGFR protein (Taniuchi et al., 1986) are significantly elevated in distal nerve at this time. In other groups of lesioned rats treated with &OHQ, 8 mm portions of nerve representing the 4-12 mm of distal nerve (and corresponding regions of contralateral nerve) were removed from rats and assayed for LNGFR content as described Cyan and Johnson, 1987 and in vivo experimental groups were determined by analysis of variance (ANOVA), followed by Dunnett's or Student-Newman-Keuls' post hoc analysis. Significant differences between means were tested at the 0.05 and 0.0 1 level.
Results
To measure the relative amount of LNGFR truncation, assays were developed where Schwann cell surface LNGFR was affinity labeled with iZ51-NGF, or metabolically labeled with 35S-cysteine. Cells and conditioned media were followed over time for the diminution of cell-associated LNGFR labeling and the appearance of NGF-Rt in the medium. Figure 1 shows that when l*SI-NGF-labeled Schwann cells were placed back in culture, the cell surface (whole) receptor content decreased over a 24 hr period. Inversely, there was no NGF-Rt in the medium of these cultures at time zero; NGF-Rt was detected in the media at 2-4 hr and increased further with time in culture. This precursorproduct relationship was also observed under conditions where LNGFR was metabolically labeled with 35S-cysteine in pulsechase experiments (Fig. 2) After incubation with cells or membranes, the NGF receptor species in the media were identified as described in Materials and Methods. The rationale for using mouse Schwann cells (and membranes) and rat SCG-CM was that 192-IgG recognized only rat NGF receptor. Thus, mouse Schwann cell NGF receptor would not be recognized in the assay and would not be visualized on the resulting gel autoradiograms. Figure 3A shows that if SCG-CM was incubated with whole mouse Schwann cells little if any cleavage of LNGFR to recognizable NGF-Rt occurred (lanes 5-l 4). However, if the same experiment was carried out with mouse Schwann cell membranes, LNGFR was converted to NGF-Rt as early as 2 hr after incubation, increasing through 8-24 hr of incubation (Fig. 3B, lanes 3-l 2) . In controls for this experiment, naive medium, not exposed to SCG cultures (Fig.  3A, lanes 1, 2) , and mouse Schwann cell-conditioned medium (Fig. 3B, lanes 13, 14) had no 192-IgG-precipitable activity. These results show that exogenous substrate (whole LNGFR) can be cleaved by the source of the putative enzyme, namely, membranes prepared from Schwann cells. To investigate possible proteolytic mechanisms involved in LNGFR truncation, Schwann cells were affinity labeled and placed back in culture for 4 hr in the presence or absence of various protease inhibitors. Figure 4A and Table 1 show that phenanthroline blocked the appearance of NGF-Rt in the medium in a concentration-dependent fashion, while causing an increased accumulation of cell surface (whole) LNGFR (Fig.  4B) . The serine protease inhibitors DFP and PMSF were without effect, as was the thiol protease inhibitor iodoacetamide (Fig.  4) . The diphenyl derivative of phenanthroline, bathophenanthroline, and 8-OHQ also effectively blocked truncation; however, other known metalloprotease inhibitors, such as EDTA, phosphoramidon, thiorphan, and peptide-based inhibitors, had no effect on truncation in whole cells. In fact, Ala-Ala-Phe-CMK and Cbz-Gly-Phe appeared to increase truncation. The lysosomal stabilizing agent NH,Cl was also without effect. Incubation with the known metalloprotease collagenase did not result in enhanced truncation. In addition, incubation of the cells at 4°C for 4 hr resulted in no truncation of receptor from the Schwann cells (see Table 1 ). Agents that caused no inhibition of truncation had no effect on cell surface LNGFR content (see Fig. 4B ). Inhibition of truncation by bathophenanthroline was also evident in Schwann cells that were metabolically labeled with 35S-cysteine, indicating that both labeling procedures yielded similar results (Fig. 5) .
Phenanthroline or bathophenanthroline had no effects on the immunoprecipitation assay: if labeled LNGFR or NGF-Rt samples were spiked with 1 mM phenanthroline or bathophenanthroline at the time of the 192-IgG addition or of the Pansorbin addition, no effect on the signal was observed in the autoradiograms (data not shown). Truncation of LNGFR occurs in C6 glioma cells, JS-1 schwannoma cells, PC1 2 cells, and A875 melanoma cells. Phenanthroline and bathophenanthroline completely blocked truncation in the glial-like cell lines C6 and JS-1, but had little if any effect on PC12 or A875 cell truncation (data not shown).
To investigate whether the truncation of Schwann cell LNGFR could occur in disrupted cells, affinity-labeled membranes were prepared and incubated at 37°C as described in Materials and Methods. Interestingly, truncation occurred in membrane preparations to approximately the same extent as seen in whole cells (Fig. 6) . As in whole Schwann cell experiments, truncation was inhibited by phenanthroline in a concentration-dependent manner, with concomitant increased membrane-associated LNGFR (Fig. 6A,B) . While bathophenanthroline and 8-OHQ were also effective, inhibition of truncation in membranes was observed with EDTA and the peptide-based metalloprotease inhibitors Cbz-Gly-Phe and Ala-Ala-Phe-CMK (Fig. 6, Table 2 ). Phen- anthroline maintained a higher rank of potency compared to the other inhibitors (Table 2) . DFP, PMSF, iodoacetamide, leupeptin, bestatin, and ethanol (vehicle) were without effect, corroborating the protease class specificity obtained with whole Schwann cell truncation studies. As with whole-cell experiments, truncation was completely inhibited when membranes were incubated at 4°C.
To gain an estimation of the metal preference of the putative truncating metalloprotease investigated in this study, truncation reconstitution experiments were carried out in phenanthrolinequenched membranes (see Materials and Methods). Zinc (ZnSO,) was found to reconstitute the truncating activity to 70% of prephenanthroline treatment levels (Fig. 7) . Reconstitution of truncation was also observed with 3 x 1O-3 M Mn2+ as well as 3 x 10m3 M Fe*+, whereas no reconstitution was seen with Ca2+, Mgz+, or Cu*+, the only other ions tested. These findings strengthen the notion that the truncating activity is a metalloprotease and that the enzyme prefers zinc.
From the foregoing experiments it appears that a metalloprotease plays a critical role in the cleavage of Schwann cell LNGFR to NGF-Rt. To address questions concerning inhibition of Schwann cell LNGFR truncation during development and regeneration, studies were carried out to determine (1) if receptor truncation could be inhibited in vivo and (2) if inhibition of truncation in vivo affected nerve regeneration events, given the hypothesis that Schwann cells express LNGFR to bind NGF (or other neurotrophins), thus presenting neurotrophic factor to regenerating neurons. From the group of metalloprotease inhibitors that blocked truncation in vitro it was found that rats tolerated repeated doses of S-OHQ but not of phenanthroline or bathophenanthroline. Thus, initial studies were conducted to examine the ability of 8-OHQ to block truncation in neonatal rats, addressing the specific question: can 8-OHQ treatment decrease the amount of NGF-Rt found in urine and blood and increase the level of LNGFR on Schwann cells of peripheral nerve? Neonates were chosen for study, as the levels of LNGFR in sciatic nerve are relatively high and decline sharply over the first several postnatal days. Similarly, the levels of urine and plasma NGF-Rt decline rapidly over the same time course. Therefore, the first 4 postnatal days provide a good period in which to examine fluctuations in LNGFR and NGFRt in rat pups treated with and without 8-OHQ. Figure 8 shows that neonatal rat sciatic nerve LNGFR content, expressed as percentage femtomoles of rZSI-NGF cross-linked/mg tissue protein, was unchanged at doses of 25 and 50 mg/kg 8-OHQ, but was significantly elevated at 75 and 100 mg/kg of the inhibitor. Urinary NGF-Rt was significantly decreased in rats treated with 75 mg/kg 8-OHQ; plasma levels of NGF-Rt were also decreased at 50 mg/kg. These results show that truncation can be inhibited in vivo by 8-OHQ.
To test whether inhibition of LNGFR truncation could have functional implications we addressed the following question: if LNGFR truncation is blocked in vivo during the course of a nerve regeneration event, will this augment the rate of regeneration, presumably by Schwann cells providing a better environment for axonal growth? The rate of sensory neuron regen-A. eration in rats treated with or without 8-OHQ was monitored at various times after a crush lesion using the nerve pinch test (see Materials and Methods). It was found that 8-OHQ (50 mg/ kg) enhanced the distance of sensory neuron regeneration at 2, 3,6, and 8 d postlesion (not shown). Figure 9 shows that 8-OHQ enhanced regeneration rate in a dose-dependent fashion at 3 d following the lesion. This occurred at doses comparable to those that inhibited truncation in neonatal rats. Consistent with results in the neonate, 8-OHQ (100 mg/kg) increased LNGFR levels in distal nerve 2.5-fold compared to vehicle (Table 3) . 8-OHQ also increased LNGFR levels in unlesioned (contralateral) nerve by 2.5-fold. Thus, the increased levels of LNGFR in distal nerve correlate with enhanced regeneration.
Discussion
The observation that no alternatively spliced variants of LNGFR mRNA exist (Hempstead and Chao, 1989; Barker et al., 199 1; Chao, 199 1) implies a precursor-product relationship between LNGFR and NGF-Rt. Through the use of affinity labeling and metabolic labeling techniques, the results of the present study show that NGF-Rt is derived from cell surface LNGFR. Further, the observation that truncation occurs with either labeling (5) 3.25* k 0.83 (8) Rats were lesioned and treated with 8-OH0 or vehicle as described for Figure 9 . Nerve segments 4-l 2 mm distal to the crust were removed, and frozen at 180°C until assayed for LNGFR as described in Materials and Methods. Comparable lengths ofnerve on the contralateral (unlesioned) side were assayed for comparison. Results are mean + SE for the number indicated in parentheses. *, p < 0.05 versus vehicle. DOSE 8-OHQ, mg/kg Figure 9 . Dose-response of 8-OHQ on sensory neuron regeneration in adult rats receiving a sciatic nerve crush lesion. Rats were lesioned and given 8-OHQ at doses of 0 (vehicle), 30, 50, 100, 175, and 300 mg/kg three times daily for 3 d. The pinch test was administered on day 3 to determine the distance of regeneration. The mean regeneration distance +-SE is expressed in millimeters distal to the crush site (n indicated within each bar). *, p < 0.05; **, p < 0.01 versus vehicle (ANOVA).
procedure suggests that truncation is not dependent on NGF occupation of LNGFR, unlike the situation for insulin-induced and epidermal growth factor-induced cleavage of their respective cell surface receptors (Lipson et al., 1988 (Lipson et al., , 1989 Decker, 1989) . The results show that the culture system described, regardless of the labeling procedure, provides a reproducible and quantitative means to study the mechanisms of LNGFR truncation in Schwann cells.
Truncated forms of several single membrane-spanning cell surface receptors have been identified. In the case of the interleukin-4 (IL-4) (Mosley et al., 1989) , IL-7 (Goodwin et al., 1990) , and polio virus receptors (Koike et al., 1990) , truncated, soluble binding sites arise from alternative splicing of receptor mRNAs. Conversely, soluble receptors for IL-2 (Rubin et al., 1985) and tumor necrosis factor (TNF) (Lantz et al., 1990; Nophar et al., 1990; Porteu et al., 1991) , as well as the lymphocyte-specific glycoprotein CD27 (Loenen et al., 1992) , arise from presumed proteolytic cleavage of cell surface forms. Since the type I and type II TNF receptors, CD27, and LNGFR display some structural similarities (Nophar et al., 1990; Loenen et al., 1992) , the protease involved in truncation of these molecules may be similar. Our results are consistent with a mechanism of proteolytic cleavage of LNGFR at or near the cell surface, rather than a mechanism involving alternatively spliced transcripts of the receptor mRNA.
The mechanism of LNGFR truncation in A875 human melanoma cells has recently been shown to occur via internalization of LNGFR, cleavage in endosomes/lysosomes, and secretion as NGF-Rt (Zupan and Johnson, 1991) . This truncation mechanism is unlikely in Schwann cells since (1) the lysosomal stabilizing agent NH,Cl had no effect on truncation, (2) there is no evidence for internalization of NGF-LNGFR complexes in Schwann cells under a variety of physiological conditions (DiStefano and Johnson, 1988a), (3) if the receptor was cleaved intracellularly, truncated receptor should have been detectable on gel autoradiograms of cell preparations, but it was not (see Fig. 4B ), and (4) Schwann cell LNGFR truncation occurs in acellular preparations, obviating lysosomal involvement. That melanoma cells (and possibly PC 12 cells) truncate LNGFR differently from their glial counterparts (Schwann cells, C6 glioma, JS-1 schwannoma) implies different functions of LNGFR in these distinct cell types.
A major observation of the present study is that a metalloprotease-like activity is responsible for the cleavage of cell surface LNGFR to NGF-Rt in rat Schwann cells. This activity is metalloprotease-like by virtue of the fact that established metalloprotease inhibitors (phenanthroline, bathophenanthroline, 8-OHQ, EDTA) block truncation whereas inhibitors defined for other protease classes do not. Enzymatic activity is supported by the observation that no truncation occurs at 4°C. The fact that truncation occurs in Schwann cell membrane preparations indicates that proteolytic activity is tightly associated with membranes. Further, our results show that the putative metalloprotease is active at physiological pH and appears to favor zinc for its activity. The observation that certain water-soluble metalloprotease inhibitors were effective only in membrane preparations, coupled with the fact that exogenous substrate (LNGFR contained in SCG-CM) was cleaved by Schwann cell membranes, but not whole cells, raises the question as to whether the truncation site lies within the intracellular domain of the receptor. It is possible that the metal accessibility site is intracellular and that cleavage actually occurs on the extracellular face. The molecular weight of NGF-Rt, as determined by SDS-PAGE (DiStefano and Johnson, 1988b; Zupan et al., 1989) would predict cleavage near the transmembrane domain, but exact amino acid analysis of the new C-terminus, formed by truncation, is needed to resolve the cleavage site.
The nature of the metalloprotease involved in LNGFR truncation is unknown. The enzyme is probably not the known metalloendopeptidase enkephalinase (EC 3.4.24.1 l), since the enkephalinase inhibitors thiorphan and phosphoramidon failed to block truncation in either whole-cell or membrane preparations. The putative metalloprotease appears to be moderately sensitive to the peptide-based inhibitors Cbz-Gly-Phe and AlaAla-Phe-CMK when assayed in Schwann cell membranes. The LNGFR sequence contains an Ala-Phe sequence at the end of the membrane-spanning domain, but no Gly-Phe sequence is evident in the molecule. Perhaps these peptides mimic putative cleavage sites only remotely related to the true cleavage site. The enzyme may represent a housekeeping metalloprotease that cleaves several membrane-juxtaposed proteins and receptors, or it could be glial specific and highly regulated during development and regeneration. Determining the molecular identity of this metalloprotease is critical to the understanding of its regulation and function in the axon-Schwann cell interaction.
Studies concerning the role of LNGFR in Schwann cells suggest that the receptor is present on the Schwann cell surface to aid the developing or regenerating neurons by presenting trophic factor to the neuron . The fact that Schwann cell LNGFR is downregulated by axonal contact Johnson, 1987, 1988; Lemke and Chao, 1988; DiStefano and Chelsea, 1990 ) and upregulated after denervation (Taniuchi et al., 1986; Heumann et al., 1987a) supports this model. The question then arises as to the significance of LNGFR truncation in peripheral glia. We have previously postulated that NGF-Rt may such as a sink that regulates endogenous neurotrophin levels, a transporter of neurotrophins, a cell signaling messenger, or a substrate-interactive molecule (DiStefano and Johnson, 1988b ). An alternative explanation may be that truncation represents a mechanism by which the Schwann cell eliminates a particular cell surface protein that is no longer required for cell-cell interaction in development. Stated another way, once the developing axon uses the NGF-LNGFR substratum, the cell requires a mechanism to dispose of it; otherwise, the axon will be attracted to this environment, impeding proper development.
In the situation of regeneration, where Schwann cell LNGFR expression recapitulates development, if increased amounts of receptor exist on Schwann cells, regenerative events may be more efficient. To test whether creating an LNGFR-rich environment may have beneficial effects during regeneration of peripheral neurons, we administered the relatively nontoxic metalloprotease inhibitor 8-OHQ to neonates and adult rats with sciatic nerve lesions and found that Schwann cell LNGFR could be regulated in viva by 8-OHQ. Further, 8-OHQ treatment augmented the rate of sensory neuron regeneration, presumably by inhibition of Schwann cell LNGFR truncation (and subsequent increased levels of cell surface receptor) in regenerating nerve. Alternatively, enhanced regeneration may have resulted from inhibition of metalloproteases involved in neuritic outgrowth of sensory neurons (Pittman, 1985) . The hypothesis that LNGFR binds neurotrophins for presentation to developing and regenerating neurons hinges upon a source of neurotrophin in developing or injured nerve to bind LNGFR. It is established that sciatic nerve NGF mRNA and NGF protein (potentially reaching local concentrations in the nanomolar range) as well as brainderived neurotrophic factor (BDNF) mRNA levels are increased in distal sciatic nerve following a cut or crush lesion (Heumann et al., 1987a,b; Meyer et al., 1992) . Further, LNGFR binds other members of the neurotrophin family (BDNF, neurotrophin-3, and neurotrophin-4) with affinities comparable to that for NGF (Hallbook et al., 199 1; Squint0 et al., 199 l) , providing the potential for Schwann cell surface LNGFR to present these factors to subsets of sensory neurons, as well as to motor and sympathetic neurons.
In summary, our results show that a membrane-associated, zinc metalloprotease activity cleaves LNGFR on Schwann cells to NGF-Rt. The results of this study demonstrate a biological significance of NGF receptor truncation, such that blockade of truncation (by inhibition of the putative metalloprotease) results in enhanced peripheral sensory nerve regeneration. We propose that receptor truncation is a novel means by which Schwann cells regulate LNGFR. Identification of the metalloprotease, as well as the truncation site on the LNGFR molecule, will allow for more specific and less toxic inhibitors of truncation to be modeled that can be tested for their potential in the treatment of peripheral nerve regeneration and peripheral neuropathy.
